These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26698133)

  • 21. [Hemopoietic stem cell transplantation for multiple myeloma-review].
    Chen WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):546-52. PubMed ID: 15363153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All transplantation-eligible patients with myeloma should receive ASCT in first response.
    Moreau P; Attal M
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):250-4. PubMed ID: 25696863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
    Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Single vs double stem cell transplantation for the treatment of multiple myeloma].
    Tamura H
    Nihon Rinsho; 2015 Jan; 73(1):85-9. PubMed ID: 25626310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving role of stem cell transplantation in multiple myeloma.
    Harousseau JL; Moreau P
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):89-95. PubMed ID: 16231846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation.
    Ikeda T; Mori K; Kawamura K; Mori T; Hagiwara S; Ueda Y; Kahata K; Uchida N; Tsukada N; Murakami S; Yamamoto M; Takahashi T; Ichinohe T; Onizuka M; Atsuta Y; Kanda Y; Okamoto S; Sunami K; Takamatsu H
    Hematol Oncol; 2019 Dec; 37(5):586-594. PubMed ID: 31674032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intensive treatment of multiple myeloma].
    Harousseau JL
    Bull Acad Natl Med; 2003; 187(2):405-13; discussion 413-5. PubMed ID: 14556449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for "De Novo" Multiple Myeloma Patients: A Phase II Study.
    Musso M; Messina G; Marcacci G; Crescimanno A; Console G; Donnarumma D; Scalone R; Pinto A; Martino M
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1932-8. PubMed ID: 26099830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there still a role for stem cell transplantation in multiple myeloma?
    Mina R; Lonial S
    Cancer; 2019 Aug; 125(15):2534-2543. PubMed ID: 30985927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The efficacy and safety of bortezomib-based induction regimen before autologous hematopoietic stem cell transplantation in patients with multiple myeloma].
    Li J; Liu JR; Huang BH; Chen M; Zheng D; Xu DR; Zou WY
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):279-83. PubMed ID: 22781947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of up-front treatment with a double stem cell transplantation in multiple myeloma.
    Eom KS; Min CK; Lee S; Kim YJ; Kim SY; Kim HJ; Lee JW; Min WS; Kim CC
    Jpn J Clin Oncol; 2006 Jul; 36(7):432-8. PubMed ID: 16782727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimal residual disease and log-reduction of plasma cells are associated with superior response after double autologous stem cell transplant in younger patients with multiple myeloma.
    Rossi G; Falcone AP; Minervini MM; De Cillis GP; De Waure C; Sisti LG; Giambra V; Valente D; Chiello V; Scalzulli PR; Carella AM; Cascavilla N
    Cytometry B Clin Cytom; 2019 May; 96(3):195-200. PubMed ID: 30549231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma.
    Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
    Clin Transplant; 2009; 23(6):839-47. PubMed ID: 20447186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine.
    Shimazu Y; Mizuno S; Fuchida SI; Suzuki K; Tsukada N; Hanagaishi A; Itagaki M; Kataoka K; Kako S; Sakaida E; Yoshioka S; Iida S; Doki N; Oyake T; Ichinohe T; Kanda Y; Astuta Y; Takamatsu H;
    Cancer Sci; 2021 Dec; 112(12):5034-5045. PubMed ID: 34644446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upfront tandem autologous non-myeloablative allogeneic stem cell transplant in high-risk multiple myeloma: a long-term single-centre experience.
    Nguyen PC; Muirhead J; Tan J; Kalff A; Bergin K; Walker P; Spencer A
    Intern Med J; 2022 Jul; 52(7):1263-1267. PubMed ID: 35808923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on the treatment of multiple myeloma.
    Kyle RA
    Oncologist; 2001; 6(2):119-24. PubMed ID: 11306723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of autologous stem-cell transplantation in multiple myeloma.
    Attal M; Harousseau JL
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):747-59. PubMed ID: 18070717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response Improvement Rather than Response Status after First Autologous Stem Cell Transplantation Is a Significant Prognostic Factor for Survival Benefit from Tandem Compared with Single Transplantation in Multiple Myeloma Patients.
    Blocka J; Hielscher T; Goldschmidt H; Hillengass J
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1280-1287. PubMed ID: 32194287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Have drug combinations supplanted stem cell transplantation in myeloma?
    Palumbo A; Cavallo F
    Blood; 2012 Dec; 120(24):4692-8. PubMed ID: 22730541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.